The first infusion of an investigational drug that aims to delay or help to prevent the earliest memory loss due to Alzheimer’s disease took place in September at Butler Hospital in Providence, R.I., researchers announced.   Funded by the National Institutes of Health (NIH) and Eisai Inc., a US subsidiaryContinue Reading

Twenty percent of Floridians, more than 4.3 million people, are 65 and older, making Florida one of the ‘grayest states’ in the nation. Consequently, it has one of the largest populations of people with Alzheimer’s disease—a projected 580,000. This number is expected to skyrocket by 24 percent to 720,000 peopleContinue Reading